• CCG chief executive to take over as STP lead in Birmingham and Solihull
  • The experienced NHS executive replaces Dame Julie Moore

The Birmingham and Solihull health economy has appointed a new leader following the retirement of Dame Julie Moore.

Paul Jennings, chief executive of the Birmingham and Solihull Clinical Commissioning Group, was appointed the new lead at a meeting of the “sustainability and transformation partnership” board on Monday.

The appointment still requires NHS Improvement and NHS England approval.

Mr Jennings has worked in NHS management in the West Midlands for decades and came out of retirement last year to lead the merger of the region’s three CCGs.

In a statement, Mr Jennings said: “As a proud Brummie, being nominated as system leader for the Birmingham and Solihull [STP] really means a lot.”

He will replace Dame Julie Moore, who is retiring as both STP lead and chief executive of University Hospitals Birmingham Foundation Trust later this year.

She is being succeeded in the latter role by the trust’s medical director and deputy chief executive, Dr David Rosser.

The Birmingham and Solihull region has undergone several big structural changes in the past two years, most notably a CCG merger and two major trust mergers.

Mr Jennings told HSJ in March ahead of the CCG merger that there were no plans for further “structural changes” in the foreseeable future, with a focus instead on provider cooperation.

However, changes in where the services are delivered are likely, with community and primary care coalescing around a “place based” care model.

Last week, HSJ also reported that UHB, which delivers the majority of acute services in the region, was undertaking a major review of clinical services.